Compare · MDVL vs PETS
MDVL vs PETS
Side-by-side comparison of MedAvail Holdings Inc. (MDVL) and PetMed Express Inc. (PETS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDVL and PETS operate in Retail-Drug Stores and Proprietary Stores (Consumer Staples), so they compete in similar markets.
- MDVL is the larger of the two at $41.4M, about 1.1x PETS ($38.2M).
- PETS has hit the wire 9 times in the past 4 weeks while MDVL has been quiet.
- PETS has more recent analyst coverage (6 ratings vs 0 for MDVL).
- Company
- MedAvail Holdings Inc.
- PetMed Express Inc.
- Price
- -
- -
- Market cap
- $41.4M
- $38.2M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Retail-Drug Stores and Proprietary Stores
- Retail-Drug Stores and Proprietary Stores
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 0
- 9
- Recent ratings
- 0
- 6
MedAvail Holdings Inc.
MedAvail Holdings, Inc. operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology. The company provides turnkey services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations. It also operates SpotRx, a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery. MedAvail Holdings, Inc. is based in Mississauga, Canada.
PetMed Express Inc.
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website and mobile app; telephone contact center; and direct mail/print through catalogs, brochures, and postcards. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Latest MDVL
- SEC Form SC 13G/A filed by MedAvail Holdings Inc. (Amendment)
- Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- US Stocks Mixed; Trimble Issues Weak Outlook
- MedAvail Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- 11 Consumer Staples Stocks Moving In Thursday's Intraday Session
- Why Container Store Group Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- Why Fortinet Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
- SEC Form 4 filed by Faulkner Robert C.
- SEC Form SC 13D/A filed by MedAvail Holdings Inc. (Amendment)
- Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Latest PETS
- Interim CEO and President Campbell Leslie C.G. was granted 60,000 shares, increasing direct ownership by 71% to 145,000 units (SEC Form 4)
- SEC Form 10-Q filed by PetMed Express Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by PetMed Express Inc.
- PetMed Express Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- PetMeds® Announces First Quarter Financial Results
- PetMed Express Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director Lacamp James was granted 55,555 shares, increasing direct ownership by 159% to 90,421 units (SEC Form 4)
- Director Batushansky Peter was granted 55,555 shares, increasing direct ownership by 153% to 91,928 units (SEC Form 4)
- Director Mennen Justin L. was granted 55,555 shares, increasing direct ownership by 130% to 98,274 units (SEC Form 4)
- PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026